These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 10296163)

  • 21. Achieving an effective committee through reorganization: the Ohio State University Hospital's experience.
    Lewis RP; Moore TD
    Hosp Formul; 1991 Feb; 26(2):120-30. PubMed ID: 10109143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generics still a favorite Rx for savings.
    Wagner M
    Mod Healthc; 1990 May; 20(21):26-8, 30, 32-3. PubMed ID: 10104890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 1996 standards. Joint Commission refines its approach.
    Hosp Food Nutr Focus; 1996 Jan; 12(5):1, 4-5, suppl 2 p.. PubMed ID: 10153639
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibiotic interchange through educational interventions in a community hospital.
    Shalansky SJ
    Am J Hosp Pharm; 1991 Dec; 48(12):2655-7. PubMed ID: 1814215
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug purchasing considerations.
    Mehl B
    Hosp Pharm; 1988 Oct; 23(10):913, 916-7. PubMed ID: 10290113
    [No Abstract]   [Full Text] [Related]  

  • 26. Policy and Procedure Manual. Processing nonformulary drug requests.
    Curr Concepts Hosp Pharm Manage; 1987; 9(4):20-1. PubMed ID: 10284439
    [No Abstract]   [Full Text] [Related]  

  • 27. The hospital formulary as a tool for quality assurance.
    Johnson WF; Kwon J
    Top Hosp Pharm Manage; 1988 Feb; 7(4):14-23. PubMed ID: 10314263
    [No Abstract]   [Full Text] [Related]  

  • 28. Replies to the question: should the practice of drug sampling be retained or eliminated?
    Hosp Formul; 1994 Oct; 29(10):720-2. PubMed ID: 10137849
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic interchange of drugs not included in the hospitaĺs pharmacotherapeutic guide: a quality program].
    Navarro de Lara S; Font Noguera I; Lerma Gaude V; López Briz E; Martínez Pascual MJ; Poveda Andrés JL
    Farm Hosp; 2004; 28(4):266-74. PubMed ID: 15369437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing an adverse drug reaction reporting program.
    Nelson RW; Shane R
    Am J Hosp Pharm; 1983 Mar; 40(3):445-6. PubMed ID: 6846354
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic substitution and better purchasing significantly reduce hospital pharmacy costs.
    Perry PA
    Hosp Mater Manage; 1990 Jan; 15(1):10-1. PubMed ID: 10103376
    [No Abstract]   [Full Text] [Related]  

  • 32. Comprehensive pharmacy-based investigational drug service.
    Benfell K; Powell SH; Kaul AF
    Am J Hosp Pharm; 1983 Jan; 40(1):64-7. PubMed ID: 6823990
    [No Abstract]   [Full Text] [Related]  

  • 33. Point: the formulary system and the emperor's new clothes.
    Green JA
    Am J Hosp Pharm; 1986 Nov; 43(11):2830-4. PubMed ID: 3799622
    [No Abstract]   [Full Text] [Related]  

  • 34. Generic drugs: boon or bust for quality?
    Sedor P
    Hospitals; 1989 Jan; 63(2):68. PubMed ID: 2910804
    [No Abstract]   [Full Text] [Related]  

  • 35. Implementing and maintaining a viable formulary.
    Kelly WN; Bender FH
    Hosp Formul; 1983 Oct; 18(10):976-8, 981-2, 987. PubMed ID: 10262828
    [No Abstract]   [Full Text] [Related]  

  • 36. Guidelines on the operation of the pharmacy and therapeutics committee and formulary.
    Linkewich JA; Prevoznik SJ
    Hosp Pharm; 1979 Jan; 14(1):7-10, 13, 16-9 passim. PubMed ID: 10240149
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacy U.R. cuts costs, drug use.
    Mosier RL
    Hosp Peer Rev; 1979 May; 4(5):70-2. PubMed ID: 10308905
    [No Abstract]   [Full Text] [Related]  

  • 38. Formulary management of biotechnological drugs.
    Herfindal ET
    Am J Hosp Pharm; 1989 Dec; 46(12):2516-20. PubMed ID: 2603888
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic interchange of fluoroquinolones at a medical center.
    Lomaestro BM
    Am J Health Syst Pharm; 2001 May; 58(10):904-7. PubMed ID: 11381495
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA action spurs change in groups' drug programs.
    Perry PA
    Hosp Mater Manage; 1989 Nov; 14(11):1, 13-4. PubMed ID: 10295911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.